Toll Free: 1-888-928-9744
Published: Aug, 2014 | Pages:
25 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Medeia Therapeutics Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Medeia Therapeutics Ltd. - Product Pipeline Review - 2014', provides an overview of the Medeia Therapeutics Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Medeia Therapeutics Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Medeia Therapeutics Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Medeia Therapeutics Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Medeia Therapeutics Ltd.'s pipeline products Reasons to buy - Evaluate Medeia Therapeutics Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Medeia Therapeutics Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Medeia Therapeutics Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Medeia Therapeutics Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medeia Therapeutics Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Medeia Therapeutics Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Medeia Therapeutics Ltd. Snapshot 4 Medeia Therapeutics Ltd. Overview 4 Key Information 4 Key Facts 4 Medeia Therapeutics Ltd. - Research and Development Overview 5 Key Therapeutic Areas 5 Medeia Therapeutics Ltd. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Medeia Therapeutics Ltd. - Pipeline Products Glance 9 Medeia Therapeutics Ltd. - Early Stage Pipeline Products 9 Preclinical Products/Combination Treatment Modalities 9 Discovery Products/Combination Treatment Modalities 10 Medeia Therapeutics Ltd. - Drug Profiles 11 MDA-107 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 MDA-308 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 MDA-409 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 MDA-107 Back Up 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Medeia Therapeutics Ltd. - Pipeline Analysis 19 Medeia Therapeutics Ltd. - Pipeline Products by Target 19 Medeia Therapeutics Ltd. - Pipeline Products by Route of Administration 20 Medeia Therapeutics Ltd. - Pipeline Products by Molecule Type 21 Medeia Therapeutics Ltd. - Pipeline Products by Mechanism of Action 22 Medeia Therapeutics Ltd. - Locations And Subsidiaries 23 Head Office 23 Appendix 24 Methodology 24 Coverage 24 Secondary Research 24 Primary Research 24 Expert Panel Validation 24 Contact Us 25 Disclaimer 25
List of Tables Medeia Therapeutics Ltd., Key Information 4 Medeia Therapeutics Ltd., Key Facts 4 Medeia Therapeutics Ltd. - Pipeline by Indication, 2014 6 Medeia Therapeutics Ltd. - Pipeline by Stage of Development, 2014 7 Medeia Therapeutics Ltd. - Monotherapy Products in Pipeline, 2014 8 Medeia Therapeutics Ltd. - Preclinical, 2014 9 Medeia Therapeutics Ltd. - Discovery, 2014 10 Medeia Therapeutics Ltd. - Pipeline by Target, 2014 19 Medeia Therapeutics Ltd. - Pipeline by Route of Administration, 2014 20 Medeia Therapeutics Ltd. - Pipeline by Molecule Type, 2014 21 Medeia Therapeutics Ltd. - Pipeline Products by Mechanism of Action, 2014 22
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.